This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Citigroup, MedAssets: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Adobe Systems (ADBE) upgraded at UBS from Neutral to Buy, UBS said. $40 price target. Survey suggests that demand is stabilizing.

Citigroup (C) downgraded at Goldman to Buy from Neutral, Goldman Sachs said. Company also removed from the Conviction List.

Cheesecake Factory (CAKE) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $36 price target. Valuation call, following the recent pullback.

CBOE Holdings (CBOE) upgraded at Credit Suisse to Outperform from Neutral. Strong fundamentals and more deals coming, Credit Suisse said. Price target raised to $32 from $25.

Copart (CPRT) rated new Buy at Goldman. $48 price target. Company can deliver consistent cash flow growth.

Coinstar (CSTR) downgraded at JP Morgan from Neutral to Underweight. $42 price target. Consensus estimates appear too high.

Fifth Third (FITB) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $17 price target. Company has the most relative excess capital.

First Solar (FSLR) estimates, target boosted at Goldman. Shares of FSLR now seen reaching $190, according to Goldman Sachs. Estimates also upped, given improved volume visibility. Buy rating.

First Solar (FSLR) downgraded at UBS from Buy to Neutral, UBS said. Valuation call, based on a $180 price target.

Foster Wheeler (FWLT) downgraded at BB&T to Hold, BB&T Capital said. Company guided toward lower near-term margins.

Goldcorp (GG) upgraded at Deutsche to Buy, Deutsche Bank said. Company is seeing solid growth an boosted its dividend. $60 price target.

Hill-Rom (HRC) upgraded at Soleil from Accumulate to Buy, Soleil Securities said. Valuation call, based on a $54 price target. Hospital spending appears to be improving.

InterActiveCorp (IACI) rated new Hold at Canaccord. $28 price target. Stock is pricing in the potential for increased competition.

LDK Solar (LDK) rated new Buy at Kaufman. $24 price target. Stock trades at a significant discount to its peers.

MedAssets (MDAS) downgraded at Deutsche to Hold. $19 price target. Company has limited earnings visibility.

MedAssets downgraded at Piper to Underweight. $15 price target. Company is seeing lower growth across the board.

MedAssets downgraded at ThinkEquity from Buy to Hold, ThinkEquity said. $18 price target. Company slashed its forward guidance.

MedAssets downgraded at Citi from Buy to Hold on disappointing 4Q10 results, Citigroup said. Price target cut to $20 from $26.

MedAssets downgraded at Baird from Outperform to Neutral. $18 price target. Company lowered its earnings outlook.

Stock quotes in this article: MDAS, ADBE, C, CAKE, CBOE, FITB, FSLR, FWLT 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 0.00 0.00%
S&P 500 1,878.61 +3.22 0.17%
NASDAQ 4,148.3380 +21.3710 0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs